2000•European Journal of CancerRequires access

Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen

M. Kaufmann, Emilio Bajetta, L. Dirix, Luis Fein, Stephen E. Jones, Jožica Červek, Camilla Fowst, Anna Polli, E. Di Salle, Giorgio Massimini, G. Piscitelli

Open publisher page 29 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Exemestane, Tamoxifen, Medicine, Breast cancer, Aromatase, Oncology, Internal medicine, Postmenopausal women

Back to paper search Browse research topics Original source

Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen — Research Paper | ScholarLens